Core Viewpoint - Aishalon Medical Technology Group Co., Ltd. successfully went public on January 21, becoming the first new A-share listed company in Jiangsu Province in 2026, raising a total of 270 million yuan through its IPO to fund the construction of a public health medical supplies industrial park [2] Group 1: Company Overview - Aishalon was established in 2015 and focuses on the research, production, and sales of disposable medical consumables used in rehabilitation care and medical protection [2] - The company provides products through ODM/OEM methods for internationally recognized medical device brands, expanding its product line into disinfection, home protection, and emergency protection [2] Group 2: Financial Performance - Aishalon's main business revenue for the years 2022 to the first half of 2025 was 572 million yuan, 572 million yuan, 689 million yuan, and 436 million yuan, with a compound annual growth rate of 9.73% [3] - The majority of the company's revenue comes from overseas sales, which accounted for 90.99%, 94.25%, 94.71%, and 96.54% of total revenue in the respective periods [3] - For 2025, Aishalon expects revenue to be between 890 million yuan and 940 million yuan, representing a year-on-year growth of approximately 28.65% to 35.89% [3] Group 3: Future Outlook - The successful IPO and subsequent implementation of fundraising projects will enhance Aishalon's production capacity and increase investment in the research and development of new medical consumables [4] - The company aims to actively expand its sterilization business and continuously optimize product quality and service levels [4]
爱舍伦在北交所成功上市 成为2026年江苏首家新增A股上市公司